Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview

Nanne Kleefstra1, Johanna Hortensius1, Kornelis JJ van Hateren1, Susan JJ Logtenberg1, Sebastiaan T Houweling2, Rijk OB Gans3, Henk JG Bilo11Diabetes Centre, Isala Clinics, Zwolle, The Netherlands; 2Langerhans Medical Research Group, The Netherlands; 3Department of Internal Medicine, University Medi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nanne Kleefstra, Johanna Hortensius, Kornelis JJ van Hateren, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/35aa06ba3c97421f8dd7002b6f0e50e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35aa06ba3c97421f8dd7002b6f0e50e8
record_format dspace
spelling oai:doaj.org-article:35aa06ba3c97421f8dd7002b6f0e50e82021-12-02T06:07:45ZSelf-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview1178-7007https://doaj.org/article/35aa06ba3c97421f8dd7002b6f0e50e82009-09-01T00:00:00Zhttp://www.dovepress.com/self-monitoring-of-blood-glucose-in-noninsulin-treated-type-2-diabetes-a3528https://doaj.org/toc/1178-7007Nanne Kleefstra1, Johanna Hortensius1, Kornelis JJ van Hateren1, Susan JJ Logtenberg1, Sebastiaan T Houweling2, Rijk OB Gans3, Henk JG Bilo11Diabetes Centre, Isala Clinics, Zwolle, The Netherlands; 2Langerhans Medical Research Group, The Netherlands; 3Department of Internal Medicine, University Medical Center Groningen, Groningen, The NetherlandsIntroduction: The effectiveness of self-monitoring of blood glucose (SMBG) in noninsulin-treated patients with type 2 diabetes (T2DM) remains unclear. We aimed to review the trials investigating the effects of SMBG in this population.Methods: Medline was searched until June 29, 2009. Randomized controlled trials (RCTs) of at least 12 weeks’ duration were included. Data on the following aspects were gathered: patient and study characteristics, effects on HbA1c, quality of life and treatment satisfaction, and methodological quality.Results: The search revealed 9 original RCTs. These studies were very heterogeneous, and 5 were classified as of high quality. The studies with the best methodology did not show an effect of SMBG on HbA1c, the studies with the worst methodological quality did. Two out of the 4 studies that assessed quality of life showed a significant change in favor of the control group, 1 study showed a significant change in favor of SMBG.Discussion and conclusion: We found an inverse relation between study quality and efficacy of SMBG. At this moment, there is no basis for general use of SMBG in noninsulin-treated T2DM patients.Keywords: blood glucose self-monitoring, diabetes mellitus, type 2, blood glucose, hemoglobin A, glycosylated Nanne KleefstraJohanna HortensiusKornelis JJ van Haterenet alDove Medical PressarticleSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol 2009, Iss default, Pp 155-163 (2009)
institution DOAJ
collection DOAJ
language EN
topic Specialties of internal medicine
RC581-951
spellingShingle Specialties of internal medicine
RC581-951
Nanne Kleefstra
Johanna Hortensius
Kornelis JJ van Hateren
et al
Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
description Nanne Kleefstra1, Johanna Hortensius1, Kornelis JJ van Hateren1, Susan JJ Logtenberg1, Sebastiaan T Houweling2, Rijk OB Gans3, Henk JG Bilo11Diabetes Centre, Isala Clinics, Zwolle, The Netherlands; 2Langerhans Medical Research Group, The Netherlands; 3Department of Internal Medicine, University Medical Center Groningen, Groningen, The NetherlandsIntroduction: The effectiveness of self-monitoring of blood glucose (SMBG) in noninsulin-treated patients with type 2 diabetes (T2DM) remains unclear. We aimed to review the trials investigating the effects of SMBG in this population.Methods: Medline was searched until June 29, 2009. Randomized controlled trials (RCTs) of at least 12 weeks’ duration were included. Data on the following aspects were gathered: patient and study characteristics, effects on HbA1c, quality of life and treatment satisfaction, and methodological quality.Results: The search revealed 9 original RCTs. These studies were very heterogeneous, and 5 were classified as of high quality. The studies with the best methodology did not show an effect of SMBG on HbA1c, the studies with the worst methodological quality did. Two out of the 4 studies that assessed quality of life showed a significant change in favor of the control group, 1 study showed a significant change in favor of SMBG.Discussion and conclusion: We found an inverse relation between study quality and efficacy of SMBG. At this moment, there is no basis for general use of SMBG in noninsulin-treated T2DM patients.Keywords: blood glucose self-monitoring, diabetes mellitus, type 2, blood glucose, hemoglobin A, glycosylated
format article
author Nanne Kleefstra
Johanna Hortensius
Kornelis JJ van Hateren
et al
author_facet Nanne Kleefstra
Johanna Hortensius
Kornelis JJ van Hateren
et al
author_sort Nanne Kleefstra
title Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
title_short Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
title_full Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
title_fullStr Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
title_full_unstemmed Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
title_sort self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
publisher Dove Medical Press
publishDate 2009
url https://doaj.org/article/35aa06ba3c97421f8dd7002b6f0e50e8
work_keys_str_mv AT nannekleefstra selfmonitoringofbloodglucoseinnoninsulintreatedtype2diabetesanoverview
AT johannahortensius selfmonitoringofbloodglucoseinnoninsulintreatedtype2diabetesanoverview
AT kornelisjjvanhateren selfmonitoringofbloodglucoseinnoninsulintreatedtype2diabetesanoverview
AT etal selfmonitoringofbloodglucoseinnoninsulintreatedtype2diabetesanoverview
_version_ 1718400045507674112